Maspin was also reported to inhibit gastric cancer (GC) cell invasion and migration by blocking the cellular ITGB1/FAK signaling pathway and in turn reducing epithelial–mesenchymal transition (EMT) and angiogenesis (32, 33). The gene discussed is PTK2; the disease is gastric cancer.